Three decades of experience with multiple financial instruments. Began career as a municipal bonds trader at Lehman Brothers in 1982. Held investment banking and institutional sales and trading positions at KeyBanc, RBC and BNP Paribas.
Perhaps more than any other time in the last six decades, the fate of markets is inextricably intertwined with the ebb and flow of geopolitics. From the ECB's attempts to use the central bank's balance sheet to influence political outcomes across the eurozone to Saudi Arabia's efforts to transform the kingdom's influence over crude prices into an instrument of foreign policy, it's become increasingly clear that one simply cannot fully comprehend market movements without a thorough understanding of concurrent political outcomes. Drawing on extensive experience in both politics and finance, Heisenberg will help demystify a world in which investors can no longer hope to conceptualize markets as existing in anything that even approximates a vacuum. "I am the one who knocks."
Brad Thomas is a research analyst and he currently writes weekly for Forbes and Seeking Alpha where he maintains research on many publicly-listed REITs. In addition, Thomas is the Senior Analyst at iREIT Forbes and Editor of the Forbes Real Estate Investor, a monthly subscription-based newsletter.
Thomas has also been featured in Forbes Magazine, Kiplinger’s, US News & World Report, Money, NPR, Institutional Investor, GlobeStreet, and Fox Business. He was the #1 contributing analyst on Seeking Alpha in 2014 (as ranked by TipRanks) and he is currently writing a book on the legendary investor Donald Trump.
Thomas has co-authored a book (The Intelligent REIT Investor) that is available on Amazon.
Thomas received a Bachelor of Science degree in Business/Economics from Presbyterian College where he played basketball. He resides in South Carolina with his wife and kids.
An independent analyst and private investor. Based in Warsaw, Poland (Europe). Professional experience comprises about 20 years in a number of financial and industrial companies. Fan of the Austrian School of Economics.
Blog: Simple Digressions (daily analysis of the precious metals market; general investment issues; sometimes articles on demand of my readers).
I am a former Investment and Commercial Banker with over 30 years experience in the field. I have been advising both individuals and institutional clients on high-yield investment strategies since 1991. As author of “High Dividend Opportunities”, a premium subscription service at Seeking Alpha, my objective is to bring investors the most profitable and newest high dividend ideas, with special focus on the Energy sector. The service includes an actively managed model Portfolio targeting an overall dividend yield of 6-9% in addition to long-term capital gains. My research aims to maximize returns by identifying undervalued securities in the High Yield space.
In addition to being a Certified Public Accountant CPA from the State of Arizona, I hold a BS Degree from Indiana University, Bloomington, and a Masters degree from Thunderbird School of Global Management (Arizona). I am also a Certified Mortgage Advisor CEMAP, a UK certification. My Research and Articles have been featured on Seeking Alpha, Investing.com, ETFdailynews, and on FXEmpire.
For more information on how to subscribe to “High Dividend Opportunities” and gain exclusive access to the portfolio, live alerts and market commentaries, check the post: Introduction to “High Dividend Opportunities” on my Instablog or just email me at firstname.lastname@example.org .
Eric Parnell, CFA, is the Founder and Director of Gerring Capital Partners. Gerring Capital is a registered investment advisory firm seeking attractive returns opportunities emphasizing value, quality and risk control. Eric also publishes The Universal premium service on Seeking Alpha targeting winning strategies in bear and bull markets across the asset class universe. Gerring Capital implements these strategies for its investors and then Eric discusses them on The Universal. Eric is also a Visiting Instructor at Ursinus College in the Department of Business and Economics. Prior to founding Gerring in 2005, Eric was the Director of Investment Communications at SEI Investments and an Economist at Moody’s Analytics.
Over 30 years of investing in individual stocks. Extensive business experience with small to mid-size companies, including as CEO. Many hundreds of blog posts on financial and economic matters since 2008. Focus on value with catalysts for upside price action. Background as a physician and pharmaceutical inventor and entrepreneur, however focus now is global and involves almost all economic categories.
I'm a tech columnist for TheStreet. I was previously responsible for Seeking Alpha's tech news coverage, as well as its Eye on Tech newsletter. Prior to that, I wrote for other financial sites and published independent investment research, primarily on tech companies.
I have a B.A. in Economics from Columbia University. I'm based out of San Diego, but grew up in Southern New Jersey. I play basketball and tennis in my spare time, am a long-time (and long-suffering) fan of Philadelphia's sports teams, and alternate daily between using an iPad Air, a Galaxy Note 3, and one or two Windows PCs.
Navellier & Associates was founded by Louis Navellier in 1987 and since then has guided thousands of investors by applying our disciplined, quantitative investment process to a broad range of equity products. Every day, investors hire Navellier to manage their assets in a private account, mutual fund, or defensive portfolio.
For over 25 years, we’ve been zeroing in on opportunities for long-term growth. We employ a veteran team of investment and client service professionals who deliver exceptional, personal service and industry-leading information to our clients.
Important Disclosures that Accompany Navellier & Associates Articles:
*Navellier may hold this security in one or more investment strategies offered to its clients.
None of the stock information, data, and company information presented herein constitutes a recommendation by Navellier or a solicitation of any offer to buy or sell any securities. Any specific securities identified and described do not represent all of the securities purchased, sold, or recommended for advisory clients. The reader should not assume that investments in the securities identified and discussed were or will be profitable.
Information presented is general information that does not take into account your individual circumstances, financial situation, or needs, nor does it present a personalized recommendation to you. Individual stocks presented may not be suitable for you. Investment in securities involves significant risk and has the potential for partial or complete loss of funds invested.
One cannot invest directly in an index. Results presented include the reinvestment of all dividends and other earnings. Graphs are for illustrative and discussion purposes only.
Although information has been obtained from and is based upon sources Navellier believes to be reliable, we do not guarantee its accuracy and the information may be incomplete or condensed. All opinions and estimates constitute Navellier's judgment as of the date of the report and are subject to change without notice. This report is for informational purposes and is not to be construed as an offer to buy or sell any financial instruments and should not be relied upon as the sole factor in an investment making decision. Any decision to purchase securities mentioned in this research must take into account existing public information on such security or any registered prospectus.
Past performance is no indication of future results.
FEDERAL TAX ADVICE DISCLAIMER: As required by U.S. Treasury Regulations, you are informed that, to the extent this presentation includes any federal tax advice, the presentation is not intended or written by Navellier to be used, and cannot be used, for the purpose of avoiding federal tax penalties. Navellier does not advise on any income tax requirements or issues. Use of any information presented by Navellier is for general information only and does not represent tax advice either express or implied. You are encouraged to seek professional tax advice for income tax questions and assistance.
Dr. El-Erian is Chief Economic Advisor at Allianz and member of its International Executive Committee. He chairs President Obama's Global Development Council, is a Financial Times Contributing Editor, a Bloomberg View columnist and author of the NYT/WSJ best seller "When Markets Collide."
Dr. El-Erian formerly served as CEO and co-CIO of PIMCO, the global investment management company. He re-joined PIMCO at the end of 2007 after serving for two years as president and CEO of Harvard Management Company, the entity that manages Harvard’s endowment and related accounts.
Dr. El-Erian also served as a member of the faculty of Harvard Business School. He first joined PIMCO in 1999 and was a senior member of PIMCO's portfolio management and investment strategy group.
Before coming to PIMCO, Dr. El-Erian was a managing director at Salomon Smith Barney/Citigroup in London and before that, he spent 15 years at the International Monetary Fund in Washington, D.C.
Dr. El-Erian has published widely on international economic and finance topics. His book, "When Markets Collide," won the Financial Times/Goldman Sachs 2008 Business Book of the Year and was named a book of the year by The Economist and one of the best business books of all time by the Independent (UK). He was named to Foreign Policy’s list of “Top 100 Global Thinkers” for 2009, 2010, 2011 and 2012.
Dr. El-Erian has served on several boards and committees, including the U.S. Treasury Borrowing Advisory Committee, the International Center for Research on Women, the Peterson Institute for International Economics and the IMF's Committee of Eminent Persons. He is currently a board member of the NBER, the Carnegie Endowment for International Peace, and Cambridge in America. He chairs the Microsoft Investment Advisory Board.
He holds a master's degree and doctorate (economics) from Oxford and received his bachelor and master degrees from Cambridge. He is an Honorary Fellow of Queens' College, Cambridge University.
I am a Certified Public Accountant (CPA) and a Certified Financial Planner (CFP) (currently do not have a private practice). I have also been a member of the American Institute of Certified Public Accountants (AICPA) for 17 years (CFF as well). I am currently employed with a global accounting firm in the Northeast area (partner). I have a masters degree in accounting + legal studies. I have audit, tax, and consulting experience with entities in the following sectors: closed-end funds, energy, financials, healthcare, homebuilders, pharmaceuticals, private equity, REITs, and telecoms. I've also have experience with C-corps., estates, high net worth individuals, LLCs, LLPs, S-corps., and trusts. I am a casual individual investor. My investing fundamentals are based on both qualitative and quantitative information. By using my analytical skills, I create specific investing ideas/strategies. I am more of a longer-term investor as opposed to day-trading.
Previous Quarterly Projection Article’s Performance vs. Actual Results:
# of Projections Stated Within All Articles: 176
# of Projections PENDING: 1
# of Projections 100% Accurate or Within Range: 163
# of Projections Inaccurate or Outside of Range: 13
Projection “Within Range” Success Rate: 163 / 176 = 92.6%
Please see the list at the bottom of this profile for the details of my past projections.
Disclaimer: I cannot own and will not give an opinion on any investments my current employer has any direct or indirect professional services with (accounting, audit, tax, consulting, etc.). This mainly consists of various mutual funds and exchange traded funds (ETF's). This includes all stocks held within these particular investment vehicles. This specified list is updated monthly. As such, most large-cap stocks are "off the table" regarding my articles. All accounting insight, analysis, and opinions stated within any articles I write (in regards to a specified stock) are entirely from my own personal research and analysis. I believe my articles are both informative and in some cases educational.
NOTE: A growing number of readers/investors, analysts, and representatives of firms have requested to be provided with my "spreadsheets/models" to help better understand certain companies/sectors. My researched data is several files of 100+ spreadsheets/models containing both stocks I write about on S.A. and stocks I choose to not write about on S.A. To reduce the repeated requests to provide such data, these spreadsheets/models are ALL linked together. As such, all current and future requests to "share" my data/models will be politely declined. Thanks for your understanding regarding this subject.
I appreciate my loyal readers and I’ll continue to try to provide high quality, in-depth articles.
NOTE: Below are the stocks I currently cover as of Sept. 2016:
Stocks Covered In Great Detail (10 mREITs; 11 BDCs; 11 Other Sectors): ACAP (Proposed Spin-Off), ACAS, ACSF, AGNC, AINV, ANH, ARCC, ARR, CMO, CYS, FSAM, FSC, FSFR, GBDC, GOOG, GPRO, MAIN, MCC, MO, MTGE, NEWT, NLY, NVS, NYMT, ORC, PFAM (Proposed Spin-Off) PSEC, PM, PRIT (Proposed Spin-Off) PYLD (Proposed Spin-Off), SLRC TRP, and WMC.
Stocks Covered In Modest Detail (9 mREITs; 3 Other Sectors): AI, AMTG, BABA, EFC, IVR, MFA, MITT, NRZ (New), PHM, PMT, SLRC, TOL, TWO
Commonly Asked Questions:
Question 1): If you are only paid per article, why make your articles so long / detailed?
- I like to provide the “nuts and bolts” of a company. As such, I strive for my articles to have some sort of “hard to obtain” facts / figures. From this data, I like to fully discuss / analyze specific topics within a particular stock. This mainly consists of a quarterly projection article and a series of articles on a company’s dividend sustainability. In certain instances, I also write articles in regards to specific, material events that occur during a quarter.
- I believe a company’s quarterly results and upcoming dividend declarations are two of the most important topics readers are requesting information on. My analysis takes the “average” article several steps further to allow readers to have access to information that is rare to public viewership. In doing so, I believe my articles are both beneficial and educational for most readers.
Question 2): How come you only write 1-2 articles a week (would like to see more)?
- As stated in my profile above, I have a full-time professional career. I write / analyze stocks in my “free time”. To provide these types of high quality / in-depth articles, I can’t see writing more than 2 articles a week. I believe “quality” should always be a higher priority versus “quantity”.
- As many readers should know by now (if you’ve followed me for a while), I not here for the monetary rewards. If that was the case, I’d write 5+ weekly articles and provide little to no engagement in each article’s comment section. I believe the comments section is as important as the article themselves b/c readers have a wide range of questions in relation to each article or the sector in general.
Question 3): What do you personally gain from writing these articles?
- I am not here trying to promote a company, book, or website. There’s nothing wrong with that. However, that’s just not what I’m about. I’m here for the “average Joe”.
- When I decided to write these articles, I based it on the notion I am filling a “special niche” per se. Using skills that have been built up over my professional career, my articles usually provide unique information that most writers either a) don’t have the technical expertise to provide or b) don’t bother providing due to the time it takes to compile such data. As such, I believe the S.A. community benefits from my articles. I solely do this b/c it’s a passion of mine and I like helping readers have accurate, reliable data that is not readily available. Yes, I understand this may seem “hard to believe” in this day and age. However, I believe some of my more “seasoned” followers know this aspect of my generosity / personality. Also, in the past there were numerous misstated “facts / notions” in various articles I saw being written by the stocks I currently cover. Since I began to write my articles here, these misstatements / misnomers have decreased which is good for this forum.
Question 4): How come you do not write about more stocks?
- To give readers the level of detail that I provide in my articles, I amass large amounts of data every quarter (or even weekly). As a direct result, a large amount of time is consumed by obtaining / analyzing this data. This would only increase if I expanded my researched portfolio of stocks.
- If I expanded the stocks I research, it would most likely take away the quality of other articles I currently am writing about. Again, this gets back to the “quality vs. quantity” metric.
- There is a fairly large range of stocks / investment vehicles I cannot write about / provide an opinion on due to various conflicts of interests (regarding my professional career). This is a topic I take VERY seriously. As such, I take all necessary precautions to avoid any remote possibility of a conflict of interest occurring.
Detailed Past Projection List:
NAV as of 3/31/2014: $0.01 per share variance; within range ($10.67 projected vs. $10.68 actual)
NAV as of 6/30/2014: $0.00 per share variance; 100% accuracy ($10.56 projected vs. $10.56 actual)
NAV as of 9/30/2014: $0.01 per share variance; within range ($10.48 projected vs. $10.47 actual)
NAV as of 12/31/2014: $0.01 per share variance; within range ($10.34 projected vs. $10.35 actual)
NAV as of 3/31/2015: $0.03 per share variance; within range ($10.27 projected vs. $10.30 actual)
NAV as of 6/30/2015: $0.06 per share variance; within range ($10.25 projected vs. $10.31 actual)
NAV as of 9/30/2015: $0.17 per share variance; within range but at the higher end ($10.00 projected vs. $10.17 actual)
NAV as of 12/31/2015: $0.25 per share variance; slightly outside range; lower end ($9.90 projected vs. $9.65 actual)
NAV as of 3/31/2016: $0.11 per share variance; within range ($9.50 projected vs. $9.61 actual)
NAV as of 6/30/2016: $0.11 per share variance; within range ($9.73 projected vs. $9.62 actual)
Fiscal Q3 2016 NII: $0.00 per share variance; within range ($0.25 projected vs. $0.25 actual)
Fiscal Q4 2016 NII: $0.005 per share variance; within range ($0.251 projected vs. $0.256 actual)
Dividends for Fiscal Q4 2014: Stated dividend was currently safe (no specific dividend declarations) which turned out to be correct for April 2014 – June 2014 dividends declared
Dividends for Fiscal Q1 2015: 100% accuracy (July. 2014 $0.110475 projected vs. $0.110475 actual) (Aug. 2014 $0.110500 projected vs. $0.110500 actual) (Sept. 2014 $0.110525 projected vs. $0.110525 actual)
Dividends for Fiscal Q2 2015: 100% accuracy (Oct. 2014 $0.110550 projected vs. $0.110550 actual) (Nov. 2014 $0.110575 projected vs. $0.110575 actual) (Dec. 2014 $0.110600 projected vs. $0.110600 actual)
Dividends for Fiscal Q3 2015^: (Jan. 2015 $0.110625 projected vs. $0.110625 actual) (Feb. 2015 $0.110650 projected vs. $0.0833 actual OUTSIDE RANGE) (Mar. 2015 $0.110675 projected vs. $0.0833 actual OUTSIDE RANGE)
^ = Correctly stated dividend would be cut. However, PSEC reduced dividends beginning in February 2015 and I projected the dividend decrease would occur in April 2015 (2 months earlier than projected)
Dividends for Fiscal Q4 2015: (April. 2015 was declared in December 2014 prior to my analysis for this quarter) 100% accuracy (May 2015 - June 2015 $0.0833 projected vs. $0.0833 actual)
Dividends for Fiscal Q1 2016: 100% accuracy (July 2015 - September 2015 $0.0833 projected vs. $0.0833 actual)
Dividends for Fiscal Q2 2016: 100% accuracy (October 2015 - December 2015 $0.0833 projected vs. $0.0833 actual)
Dividends for Fiscal Q3 2016: 100% accuracy (January 2016 - March 2016 $0.0833 projected vs. $0.0833 actual)
Dividends for Fiscal Q4 2016: 100% accuracy (April 2016 - June 2016 $0.0833 projected vs. $0.0833 actual)
Dividends for Fiscal Q1 2017: 100% accuracy (July 2016 - August 2016 $0.0833 projected vs. $0.0833 actual) (September 2016 = PENDING)
BV as of 6/30/2013: $0.11 per share variance; within range ($25.40 projected vs. $25.51 actual)
BV as of 9/30/2013: $1.36 per share variance; MATERIALLY OUTSIDE RANGE ($26.63 projected vs. $25.27 actual)
BV as of 12/31/2013: $0.58 per share variance; within range lower end ($24.51 projected vs. $23.93 actual)
BV as of 3/31/2014: $0.04 per share variance; within range ($24.45 projected vs. $24.49 actual)
BV as of 6/30/2014: $0.66 per share variance; within range higher end ($25.60 projected vs. $26.26 actual)
BV as of 9/30/2014: $0.35 per share variance; within range ($25.19 projected vs. $25.54 actual)
BV as of 12/31/2014: $0.29 per share variance; within range ($25.45 projected vs. $25.74 actual)
Comprehensive Income for Q1 2015: $0.02 per share variance; within range ($0.48 per share projected vs. $0.46 per share actual)
BV as of 3/31/2015: $0.11 per share variance; within range ($25.64 projected vs. $25.53 actual)
BV as of 6/30/2015: $0.24 per share variance; within range ($24.24 projected vs. $24.00 actual)
BV as of 9/30/2015: $0.44 per share variance; within range lower end ($23.44 projected vs. $23.00 actual)
BV as of 10/31/2015: $0.06 per share variance; within my monthly $0.30 per share range ($22.98 projected vs. $23.04 actual)
BV as of 11/30/2015: $0.27 per share variance; within my monthly $0.30 per share range ($22.25 projected vs. $22.52 actual)
BV as of 12/31/2015: $0.01 per share variance; within range ($22.60 projected vs. $22.59 actual)
BV as of 1/31/2016: $0.01 per share variance; within range ($22.39 projected vs. $22.40 actual)
BV as of 2/29/2016: $0.09 per share variance; within range ($22.82 projected vs. $22.73 actual)
BV as of 3/31/2016: $0.16 per share variance; within range ($22.25 projected vs. $22.09 actual)
BV as of 6/30/2016: $0.12 per share variance; within range ($22.10 projected vs. $22.22 actual)
Dividend for Q1 2013: $0.00 per share variance; 100% accuracy ($1.25 projected vs. $1.25 actual)
Dividend for Q2 2013: Correctly stated dividend cut would occur; $0.15 per share variance; within range higher end ($0.90 projected vs. $1.05 actual)
Dividend for Q3 2013: Correctly stated another dividend cut would occur; $0.10 per share variance; within range ($0.90 projected vs. $0.80 actual)
Dividend for Q4 2013: Correctly stated another dividend cut would occur; $0.05 per share variance; within range ($0.60 projected vs. $0.65 actual)
Dividend for Q1 2014: Correctly stated dividend would be stable; $0.00 per share variance; 100% accuracy ($0.65 projected vs. $0.65 actual)
Dividend for Q2 2014: Correctly stated dividend would be stable; $0.00 per share variance; 100% accuracy ($0.65 projected vs. $0.65 actual)
Dividend for Q3 2014: Correctly stated dividend would be stable; $0.00 per share variance; 100% accuracy ($0.65 projected vs. $0.65 actual)
Dividend for November 2014 - April 2015: Correctly stated dividend would be stable; 100% accuracy ($0.22 projected vs. $0.22 actual)
Dividend for May 2015: Company declared dividend several weeks ahead of schedule; prior to my quarterly dividend sustainability analysis. As such, no dividend projection was provided for May 2015:
Dividend for June 2015 - August 2015: Correctly stated dividend would be stable; 100% accuracy ($0.20 projected vs. $0.20 actual)
Dividend for September 2015*: INCORRECTLY stated dividend would modestly reduced; ($0.18 projected vs. $0.20 actual)
Dividend for October and November 2015: Not provided but stated increased risk to reduction by end of 2015 / early 2016.
Dividend for December 2015**: Stated dividend would be stable; highest probability ($0.20 projected vs. $0.20 actual)
Dividend Declaration for January 2016: Not provided due to time constraints.
Dividend for February 2016 - July 2016: Correctly stated dividend would be stable; 100% accuracy ($0.20 projected vs. $0.20 actual)
Dividend for August 2016 - AGNC declared a ($0.02) per share decrease prior to my quarterly dividend sustainability analysis. However, in my prior quarter's analysis, I stated I thought AGNC's monthly dividend should be stable over the near-term (3-6 months). As such, I conclude this in an INCORRECT forward projection.
BV as of 12/31/2013***: $0.40 per share variance; within range lower end ($21.87 projected vs. $21.47 actual)
BV as of 3/31/2014***: $0.16 per share variance; within range ($21.94 projected vs. $21.78 actual)
BV as of 6/30/2014***: $0.13 per share variance; within range ($22.60 projected vs. $22.73 actual)
BV as of 9/30/2014***: $0.29 per share variance; within range ($21.95 projected vs. $22.24 actual)
BV as of 12/31/2014***: $0.19 per share variance; within range ($22.10 projected vs. $21.91 actual)
BV as of 3/31/2015***: $0.20 per share variance; within range ($21.80 projected vs. $22.00 actual)
BV as of 6/30/2015***: $0.30 per share variance; within range ($22.00 projected vs. $21.70 actual)
BV as of 9/30/2015***: $0.17 per share variance; within range ($20.10 projected vs. $19.93 actual); excluding "one-time" ($0.20) per share impairment charge related to RCS; $0.03 per share variance ($20.10 projected vs. $20.13 actual; excluding impairment charge).
BV as of 12/31/2015***: $0.16 per share variance; within range ($19.50 projected vs. $19.66 actual)
BV as of 3/31/2016***: $0.22 per share variance; within range ($19.25 projected vs. $19.03 actual)
BV as of 6/30/2016***: $0.28 per share variance; within range towards higher end ($19.15 projected vs. $19.47 actual)
Dividend for Q3 2013***: Correctly stated dividend would be modestly cut; $0.00 per share variance; 100% accuracy ($0.70 projected vs. $0.70 actual)
Dividend for Q4 2013***: Correctly stated dividend would be slightly cut; $0.00 per share variance; 100% accuracy ($0.65 projected vs. $0.65 actual)
Dividend for Q1 2014***: Correctly stated dividend would be stable; $0.00 per share variance; 100% accuracy ($0.65 projected vs. $0.65 actual)
Dividend for Q2 2014 - Q4 2014***: Correctly stated dividend would be stable; $0.00 per share variance; 100% accuracy ($0.65 projected vs. $0.65 actual)
Dividend for Q1 2015***: INCORRECTLY stated dividend would be stable; ($0.15) per share variance; ($0.65 projected vs. $0.50 actual) In my opinion, the severity of this cut was very disappointing.
Dividend for Q2 2015***: Correctly stated dividend would be stable; $0.00 per share variance; 100% accuracy ($0.50 projected vs. $0.50 actual)
Dividend for Q3 2015***: INCORRECTLY stated dividend would be stable; ($0.10) per share variance; ($0.50 projected vs. $0.40 actual) In my opinion, the severity of this cut was very disappointing once again.
Dividend for Q4 2015 - Q2 2016***: Correctly stated dividend would be stable; $0.00 per share variance; 100% accuracy ($0.40 projected vs. $0.40 actual)
BV as of 3/31/2014***: $0.10 per share variance; within range ($12.40 projected vs. $12.30 actual)
BV as of 6/30/2014***: $0.43 per share variance; SLIGHTLY OUTSIDE RANGE higher end ($12.80 projected vs. $13.23 actual)
BV as of 9/30/2014***: $0.07 per share variance; within range ($12.95 projected vs. $12.88 actual)
BV as of 12/31/2014***: $0.15 per share variance; within range ($12.95 projected vs. $13.10 actual)
BV as of 3/31/2015***: $0.32 per share variance; SLIGHTLY OUTSIDE RANGE; lower end ($13.20 projected vs. $12.88 actual)
BV as of 6/30/2015***: $0.17 per share variance; within range ($12.15 projected vs. $12.32 actual)
BV as of 9/30/2015***: $0.16 per share variance; within range ($12.15 projected vs. $11.99 actual)
BV as of 12/31/2015***: $0.13 per share variance; within range ($12.60 projected vs. $12.73 actual) (most of the variance was in relation to the accretive effect of Q4 2015 share repurchases)
BV as of 3/31/2016***: $0.04 per share variance; within range ($11.65 projected vs. $11.61 actual)
BV as of 6/30/2016***: $0.35 per share variance; within range towards lower end ($11.85 projected vs. $11.50 actual)
Dividend for Q1 2014 - Q1 2015***: Correctly stated dividend would be stable; $0.00 per share variance; 100% accuracy ($0.30 projected vs. $0.30 actual)
Dividend for Q2 2015***: INCORRECTLY stated dividend would be reduced; $0.05 per share variance; ($0.25 projected vs. $0.30 actual)
Dividend for Q3 2015 - Q2 2016***: Correctly stated dividend would be stable; $0.00 per share variance; 100% accuracy ($0.30 projected vs. $0.30 actual)
NAV as of 3/31/2013: $0.03 per share variance; within range ($9.87 projected vs. $9.90 actual)
NAV as of 6/30/2013: $0.04 per share variance; within range ($9.94 projected vs. $9.90 actual)
NAV as of 9/30/2013: $0.01 per share variance; within range ($9.86 projected vs. $9.85 actual)
NAV as of 12/31/2013: $0.00 per share variance; 100% accuracy ($9.85 projected vs. $9.85 actual)
NAV as of 3/31/2014: $0.00 per share variance; 100% accuracy ($9.81 projected vs. $9.81 actual)
NAV as of 6/30/2014: $0.06 per share variance; within range lower end ($9.77 projected vs. $9.71 actual)
NAV as of 9/30/2014: $0.01 per share variance; within range ($9.65 projected vs. $9.64 actual)
NAV as of 12/31/2014: $0.37 per share variance; MATERIALLY OUTSIDE RANGE ($9.54 projected vs. $9.17 actual)
NAV as of 3/31/2015: $0.21 per share variance; OUTSIDE RANGE ($8.97 projected vs. $9.18 actual)
NAV as of 6/30/2015: $0.00 per share variance; 100% accuracy ($9.13 projected vs. $9.13 actual) (projections + article were provided to certain interested parties outside S.A.)
NAV as of 9/30/2015: $0.05 per share variance; within range ($8.95 projected vs. $9.00 actual) (projections + analysis were provided to certain interested parties; did not have enough time to provide an article)
FSC’s Dividend Sustainability Analysis Through Fiscal Q3 2013: Stated moderate to material dividend cut is needed; 100% accurate because company cut dividend beginning in December 2013
Dividend for Fiscal Q3 2015****: Correctly stated very low risk for a dividend reduction; dividend would be stable; $0.00 per share variance; 100% accuracy (April 2015 $0.06 projected vs. $0.06 actual) (May 2015 $0.06 projected vs. $0.06 actual) (June 2015 $0.06 projected vs. $0.06 actual)
Dividend for September 2015 - February 2016****: Correctly stated very low risk for a dividend reduction; dividend would be stable; $0.00 per share variance; 100% accuracy (September 2015 $0.06 projected vs. $0.06 actual) (October 2015 $0.06 projected vs. $0.06 actual) (November 2015 $0.06 projected vs. $0.06 actual) (December 2015 $0.06 projected vs. $0.06 actual) (January 2016 $0.06 projected vs. $0.06 actual) (February 2016 $0.06 projected vs. $0.06 actual)
Dividend for September 2016 - November 2016 Correctly stated very low risk for a dividend reduction; dividend would be stable; $0.00 per share variance; 100% accuracy ($0.06 per share projected vs. $0.06 per share actual)
NAV as of 12/31/2013: $0.12 per share variance; within range lower end (wider range b/c first full quarter of operations) ($15.22 projected vs. $15.10 actual)
NAV as of 3/31/2014: $0.03 per share variance; within range ($15.13 projected vs. $15.10 actual)
NAV as of 6/30/2014: $0.01 per share variance; within range ($15.14 projected vs. $15.13 actual)
NAV as of 9/30/2014: $0.02 per share variance; within range ($12.63 projected vs. $12.65 actual)
NAV as of 12/31/2014: $0.10 per share variance; within range (at lowest end) ($12.635 projected vs. $12.534 actual)
NAV as of 3/31/2015: $0.08 per share variance; within range ($12.38 projected vs. $12.46 actual)
NAV as of 6/30/2015: $0.15 per share variance; within range (at lowest end) ($12.38 projected vs. $12.23 actual)
NAV as of 9/30/2015: $0.18 per share variance; within range (at higher end) ($11.93 projected vs. $12.11 actual)
NAV as of 12/31/2015: Not provided to readers due to the fact the company "pre-announced" NAV prior to my quarterly projection analysis (due to a material reduction)
NAV as of 3/31/2016: $0.17 per share variance; within range (at higher end) ($11.01 projected vs. $11.18 actual)
NAV as of 6/30/2016: $0.31 per share variance; MODESTLY OUTSIDE range ($11.30 projected vs. $10.99 actual)
Dividend Declaration for December 2015 - February 2016: Correctly stated very low probability (10%) for a dividend reduction; dividend would be stable; $0.00 per share variance; 100% accuracy (December 2015 $0.075 projected vs. $0.075 actual) (January 2016 $0.075 projected vs. $0.075 actual) (February 2016 $0.075 projected vs. $0.075 actual)
Dividend Sustainability Analysis Through Q4 2013: Stated material dividend cut was needed as soon as the next quarter; 100% accurate because company cut dividend in Q1 2014 from $0.80 per share (regular dividend portion) to $0.67 per share.
Dividend for Q4 2014*****: Stated dividend would be stable; $0.00 per share variance; 100% accuracy ($0.70 projected vs. $0.70 actual)
Dividend for Q1 2015***: Stated dividend would be "relatively" stable; accurate because company only cut its dividend by ($0.03) per share which, when calculated, was only a "minor" (< 5%) reduction
Dividend for Q2 2015***: Stated heightened risk for another minor - modest dividend reduction; accurate because company cut its dividend by ($0.03) per share which, when calculated, was another "minor" (< 5%) reduction
Dividend for Q3 2015: Correctly stated dividend would be modestly cut; $0.00 per share variance; 100% accuracy ($0.60 projected vs. $0.60 actual
Dividend for Q3 2015*****: Stated dividend had a modest to high probability (50% - 75%) of being reduced; 100% accurate because company reduced monthly dividends from $0.18 per share to $0.14 per share beginning in July 2015.
Dividend for August 2015 - July 2016: Correctly stated each month dividend would be stable; 100% accuracy ($0.14 projected vs. $0.14 actual)
BV as of 9/30/2015: $0.06 per share variance; within range ($11.63 projected vs. $11.69 actual)
BV as of 12/31/2015: $0.09 per share variance; within range ($11.74 projected vs. $11.65 actual)
BV as of 3/31/2016: $0.09 per share variance; within range ($11.10 projected vs. $11.01 actual)
BV as of 6/30/2016: $0.01 per share variance; within range ($10.86 projected vs. $10.85 actual)
Dividend Declaration for Calendar Q2 2015****: Correctly stated low risk for a dividend reduction; dividend would be stable; $0.00 per share variance; 100% accuracy (April 2015 $0.175 projected vs. $0.175 actual) (May 2015 $0.175 projected vs. $0.175 actual) (June 2015 $0.175 projected vs. $0.175 actual).
Dividend Declaration for September - November 2015: Correctly stated very low risk for a dividend reduction; dividend would be stable; $0.00 per share variance; 100% accuracy (September 2015 $0.175 - $0.18 projected vs. $0.180 actual) (October 2015 $0.175 - $0.18 projected vs. $0.180 actual) (November 2015 $0.175 - $0.18 projected vs. $0.180 actual).
Special Periodic Dividend Declaration for 2015: Correctly stated high probability of a special periodic dividend paid in December 2015; exactly at my projected mean: ($0.25 - $0.30 projected vs. $0.275 actual).
Dividend Declaration for December 2015 - February 2016: Correctly stated very low risk for a dividend reduction; dividend would be stable; $0.00 per share variance; 100% accuracy (December 2015 $0.18 projected vs. $0.180 actual) (January 2016 $0.18 projected vs. $0.180 actual) (February 2016 $0.18 projected vs. $0.180 actual).
Dividend Declaration for March 2016 - May 2016: Correctly stated very low risk for a dividend reduction; dividend would be stable; $0.00 per share variance; 100% accuracy (March 2016 $0.18 - $0.185 projected vs. $0.180 actual) (April 2016 $0.18 - $0.185 projected vs. $0.180 actual) (May 2016 $0.18 - $0.185 projected vs. $0.180 actual).
Dividend Declaration for June 2016 - August 2016: Correctly stated very low risk for a dividend reduction; dividend would be stable; $0.00 per share variance; 100% accuracy (June 2016 $0.18 - $0.185 projected vs. $0.180 actual) (July 2016 $0.18 - $0.185 projected vs. $0.180 actual) (August 2016 $0.18 - $0.185 projected vs. $0.180 actual).
Special Periodic Dividend Declaration for First-Half 2016: Correctly stated high probability of a special periodic dividend paid in June 2016; exactly at my projected mean: ($0.25 - $0.30 projected vs. $0.275 actual).
Dividend Declaration for September 2016 - November 2016: Correctly stated very low risk for a dividend reduction; dividend would be stable; $0.00 per share variance; 100% accuracy (Sept. 2016 $0.18 - $0.185 projected vs. $0.185 actual) (October 2016 $0.18 - $0.185 projected vs. $0.185 actual) (November 2016 $0.18 - $0.185 projected vs. $0.185 actual).
Q4 2015 Adjusted Diluted EPS: $0.00 per share variance; 100% accuracy ($0.67 projected vs. $0.67 per share actual)
Q1 2016 Adjusted Diluted EPS: $0.02 per share variance; within range lower end of $0.04 per share range ($0.70 projected vs. $0.72 per share actual)
Q2 2016 Adjusted Diluted EPS: $0.01 per share variance; 100% accuracy ($0.80 projected vs. $0.81 per share actual)
* = Stated there was a 60% probability dividend would be reduced to $0.18 per share; a 30% probability dividend would remain stable at $0.20 per share
** = Stated there was a 45% probability dividend would be reduced to $0.16 - $0.19 per share
*** = Provided within an AGNC article
**** = Provided within a PSEC article
***** = Provided within a NLY article
Who I Am: I'm a retired individual investor. I retired at the end of 2013 after a 35 year career as a professor and research scientist at a major research university. So -- a career as a researcher and an educator, which is what I hope to continue here. Virtually every good teacher I've ever known says some version of "I learn more from teaching than my students do." There's a lot of truth in that, enough that there's an underlying selfish motivation for my writing here as I continue to learn about investing.
My professional life involved multiple international projects and collaborations, so I traveled extensively over those 35 years. I plan to continue doing so in my retirement. One consequence is that I'm liable to disappear from the site for extended periods. How can you miss me if I don't go away?
My investing priorities are building and refining portfolios designed to provide income and capital growth: Income for my retirement needs, and capital growth for my estate. My investing interests are tax-advantaged income from a range of sources, portfolio strategies, information- and bio-technology, and momentum-based strategic allocation.
Why I Write for Seeking Alpha: I learned long ago that "writing is nature's way of letting you know how sloppy your thinking is." The line comes from a Guindon comic strip of many years ago, and could not be more true in my case. When I did research professionally, I learned that writing it up forces me to think about details I might otherwise overlook. It's how I spent my working career, so it comes more or less naturally to me. I consider it an essential part of doing any research. So, the writing I do here is as much for myself as for the reader. As I started to contribute articles here, they grew out of research for my personal investment portfolios. They're based on things I've uncovered that are of interest to me and may be of interest to others of like mind. My primary purposes in writing them are to help clarify my thinking and to get feedback from others who may have very different opinions. It's those thoughtful comments that make Seeking Alpha such an important resource.
I try to actively engage myself in the comment streams in my articles, contributing what I can and learning from others. As a research scientist I spent a career spanning four decades devoted to free exchange of information vetted by rigorous peer review. It's a concept I firmly believe in. I hope to bring that approach to my interactions and contributions on Seeking Alpha and welcome critical commentary on anything I may contribute here. I especially encourage and appreciate thoughtful comments from those who disagree with me (although I will ignore obvious trolls and encourage others to do so as well). So, go ahead, start a conversation in the comment threads. It's one of the best things about Seeking Alpha.
My Investment Philosophies and Strategies: I maintain two portfolios. My income portfolio is a taxable account. I try to keep it separate from the growth portfolio which is housed in a series of IRAs, traditional and Roth. My income focus is on tax-advantaged income. In 2016 I face minimum required withdrawals from my tax-deferred accounts, so tax efficiency is an important consideration. The IRAs I see as my estate and are focused on generational wealth building. That means the growth portfolios have a long-term horizon, well beyond what an investor of my age might be expected to maintain.
Who Is Left Banker? Ah yes, the name. When I first joined Seeking Alpha I had no intention of being anything but an occasional reader. I saw it as another research site. So, I just ported a name I've used on other sites. I spent some of the best times of my life living on the left bank of the Seine and am always thrilled to be back in La Belle Paris. Add that I also like it because I find several subtle word plays there; I'll leave it to you to decipher that comment.
Finally, I've chosen to remain anonymous, which I feel obligated to justify. First, I have no professional role in finance and nothing to sell, so there is no advantage to be gained by "making a name for myself' here. Second, I value my privacy and have kept my internet presence as low-key as my professional life allowed. I certainly want to avoid any possibility of some internet connection trying to track me down. Odds against that happening are, of course, outrageously long, but why take them on at all?
Disclosures: I have no ties to the financial or security industries in any form. My interests are strictly personal. The banker part of the nym has absolutely no relationship to the profession of the same name. Readers should be aware that I am an investing novice, some might say dilettante. I do not give advice; what I publish is much more in line with a research notebook. Anyone who finds anything of interest will necessarily want to do his or her complete research and due diligence. It would be foolish to rely on my conclusions without having done so.
Bob O’Donnell is the founder and chief analyst of TECHnalysis Research, LLC a technology consulting and market research firm that provides strategic consulting and market research services to the technology industry and professional financial community. You can follow him on Twitter @bobodtech.
Brad Lamensdorf, a seasoned money manager and market strategist, is the editor of The Lamensdorf Market Timing Report, a newsletter designed to help investors improve performance via market timing by assessing the environment of the stock market using a variety of technical, fundamental and sentiment-oriented tools from powerful independent research firms. Many investors mechanically enter and depart the market without a true “game plan.” Studies have shown that retail investors, in particular, are very poor market timers, tending to invest at or near market peaks and sell at or near market lows. The newsletter is designed to provide risk parameters for both professional and retail investors around the short-term stock market environment, giving subscribers better insight about when to allocate assets into or out of the equity markets.
Lamensdorf, a frequent guest commentator and analyst on major business networks including CNBC, CNN and Fox Business News, also serves as a Portfolio Manager and Principal of Ranger Alternative Management LP, a sub-advisor to the Advisor Shares Ranger Equity Bear Exchange Traded Fund (NYSE: HDGE). In this role, he conducts top-down technical evaluations of broader market liquidity, sentiment and breadth to help identify short and intermediate-term market trends, manage exposure and mitigate risk. HDGE was launched in 2011 and is the first and sole actively managed, short-only ETF in existence.
Lamensdorf, also has managed investment portfolios for the Hughes family and acted as principal of Tarpon Partners, managing a long/short fund that was up more than 150% gross over six years. Earlier in his career, he was as an equity trader/market strategist for Taylor and Company, the Bass brothers’ trading arm, co-managing a short-only strategy in a derivative format with notional exposure. He also served as the in-house market timing strategist for the entire internal and external network of Bass managers.
Editor for The Biotech Forum (www.biotechforumsa.com), the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune 100 firm for a decade. For Free weekly investment reports on small, attractive biotech stocks just register at www.bretjenseninvests.com
Ian Bezek worked for 3 years as an analyst at a New York-based hedge fund. He's currently living in Mexico, pursuing some entrepreneurial opportunities.
Feel free to contact him regarding investments, writing, or speaking opportunities.
As Managing Editor - Opinion and Analysis, I lead the Seeking Alpha editorial team dedicated to curation of crowdsourced investment research and commentary. My primary responsibilities are to grow the site's audience, deepen user engagement, and improve editorial processes. I am a CFA charterholder and member of the CFA Society Washington, DC.
A veteran of the pharma industry. Specializing in the analysis of small pharma companies with a focus on the pipeline and opportunities for licensing or major deals with large pharma. Financial analysis including burn rate, venture capital funding, and cash flow.
Cory Renauer is a long-term dividend-growth investor. He is always on the lookout for well managed companies with predictable earnings growth, significant economic advantages over their competitors, and a commitment to increasing shareholder value.
WisdomTree launched its first ETFs in June of 2006, and is currently the industry's fifth largest ETF provider.
The WisdomTree Seeking Alpha profile will feature content by some of our leading analysts including:
Luciano Siracusano is WisdomTree's Chief Investment Strategist and Head of Sales. He is the co-creator with CEO Jonathan Steinberg of WisdomTree's patented Indexing methodology and has led the firm's sales force since 2008. Luciano is a regular guest on CNBC and FOX Business, and speaks frequently on ETFs, indexing and global financial markets. A former equity analyst at ValueLine, Luciano began his career as a speechwriter for former New York Governor Mario Cuomo and HUD Secretary Henry Cisneros. He graduated from Columbia University with a B.A. in Political Science in 1987.
As WisdomTree’s Director of Research, Jeremy Schwartz offers timely ideas and timeless wisdom on a bi-monthly basis. Prior to joining WisdomTree, Jeremy was Professor Jeremy Siegel's head research assistant and helped with the research and writing of Stocks for the Long Run and The Future for Investors. He is also the co-author of the Financial Analysts Journal paper “What Happened to the Original Stocks in the S&P 500?” and the Wall Street Journal article “The Great American Bond Bubble.”
Christopher Gannatti began at WisdomTree as a Research Analyst in December 2010, working directly with Jeremy Schwartz, CFA®, Director of Research. He is involved in creating and communicating WisdomTree’s thoughts on the markets, as well as analyzing existing strategies and developing new approaches. Christopher came to WisdomTree from Lord Abbett, where he worked for four and a half years as a Regional Consultant.
Rick Harper serves as the Head of Fixed Income and Currency for WisdomTree Asset Management, where he oversees fixed income and currency products developed through our collaborations with the BNY Mellon Corporation and Western Asset Management. Rick has over 19 years investment experience in strategy and portfolio management positions at prominent investment firms. Prior to joining WisdomTree in 2007, Rick held senior level strategist roles with RBC Dain Rauscher, Bank One Capital Markets, ETF Advisors, and Nuveen Investments.
Bradley Krom joined WisdomTree as a member of the Fixed Income and Currency team in December 2010. He is involved in creating and communicating WisdomTree’s thoughts on currency and fixed income markets, as well as analyzing existing and new fund strategies. Prior to joining WisdomTree, Bradley served as a senior trader on a proprietary trading desk at TransMarket Group.
Tripp Zimmerman, Research Analyst
Tripp Zimmerman began at WisdomTree as a Research Analyst in February 2013. He is involved in creating and communicating WisdomTree’s thoughts on the markets, as well as analyzing existing strategies and developing new approaches. Prior to joining WisdomTree, Tripp worked for TD Ameritrade as a fixed income specialist. Tripp also worked for Wells Fargo Advisors, TIAA-CREF and Evergreen Investments in various investment related roles. Tripp graduated from The University of North Carolina at Chapel Hill with a dual degree in Economics and Philosophy. Tripp is a holder of the Chartered Financial Analyst designation.
Jonathan Steinberg, CEO
Prior to establishing WisdomTree, Jonathan founded, and served as Chairman and CEO of Individual Investor Group, Inc. From 1998 to 2004, he held the role of Editor-in-Chief of Individual Investor and Ticker magazines. Before his entrepreneurial accomplishments, Jonathan was an Analyst in the Mergers & Acquisitions division at Bear Stearns & Co. He attended The Wharton School at the University of Pennsylvania and is the author of Midas Investing, published by Random House in 1996.
Zach Hascoe, Capital Markets
Zach Hascoe began at WisdomTree in August 2010, and works directly with David Abner, Head of Capital Markets. The Capital Markets group is involved in all aspects of the WisdomTree ETFs including product development, helping to seed and bring new products to market, as well as trading strategies and best execution strategies for the client base. Zach works closely with the trading and liquidity community and does analytics on ETF baskets and the capital markets. He is a frequent contributor to the WisdomTree blog on topics related to the capital markets, liquidity, structure and best execution. In addition, he manages the hedge fund relationships for the firm. Zach received a B.A. from Bucknell University and was Captain of the Bucknell Tennis Team.
I am an analyst and 2017 Level III Candidate in the CFA Program that has gained experience in the investment industry through positions as a proprietary trader and a portfolio management administrator. I began contributing to Seeking Alpha as a way to share my thoughts on the biopharmaceutical industry. I discussed ways to minimize risk in biopharmaceutical investing through conservative pipeline valuation and balance sheet analysis to identify companies presenting a compelling valuation to potential investors. I also touched on ways to apply knowledge of the markets to improve personal finance. My pieces included either stock-specific analysis or general biopharmaceutical investing discussion through my Biotech Weekly blog. My research appeared on the websites of CNBC, Seeking Alpha, Reuters, Google Finance, Morningstar, NASDAQ, and MarketWatch.
Note: Articles and comments are my own opinions, are not related to the opinions of my employer, and should not be considered investment advice. Make sure to do your own due diligence before making an investment decision. Thanks!
I am a Ph.D. level scientist at a major pharmaceutical company. Previously I was an NIH Cancer Postdoctoral fellow at UPENN. Through my extensive research background, I am able to quickly decipher clinical information and act on it. I specialize in analyzing and trading biotech/healthcare stocks both long and short. I maintain a few core positions and trade clinical events based on extensive research to realize large percentage gains. I am open to opportunities in consulting for financial firms or local advisors. Please contact me if you are interested.
Richard Zeits is an Oil & Gas industry analyst and consultant. His background includes fourteen years as Energy industry-focused investment banker, portfolio manager and senior investment analyst with bulge bracket firms in New York. Zeits Energy Analytics use elaborate proprietary analytics and data bases to provide in-depth industry research, market intelligence, and forecasting.
Dallas currently owns and operates as CEO an Austin-based enterprise consulting firm that specializes in private company lifecycle management, up to and including taking companies public, and in helping consult publicly traded companies ranging in market cap from $100 million to $500 million. He has a specialization in deal flow management and is often the referring and closing source of Joint Ventures and broader M&A. Dallas often works directly with management teams and Boards of microcap and stressed equity companies in which he or members of his professional network are heavily invested. This includes helping with overall strategy, helping with capital structure management, helping facilitate liquidity, helping facilitate Joint Ventures and broader M&A, and helping restructure the business segments if necessary. Recently Dallas has been interviewed by The Pittsburgh Business Times, The Banker, Columbus Business First, Houston Business Journal, The Deal, Energy Intelligence, and his tweets have been used by CNBC to highlight hot button issues regarding Carl Icahn, Bill Ackman, Nelson Peltz’s takeover attempts at DuPont, etc. Dallas has also been quoted and sourced to by StreetSweeper.org, Marcellus.com, MarcellusDrilling.com, Bakken.com, OilOnline.com, and other physical and online publications. "One place of great inefficiency is in the stressed equity markets – or the markets in which a company appears as bankruptcy or a breakup is inevitable. As equities become stressed they often sell down to absurd levels of value that present, should there be value to be unlocked, opportunities for “venture level” returns. These often range in the 3X-10X range. With my unique ability to actually improve business outcomes by working directly with a company and management/Board I’m in a position, should I view the underlying business as salvageable, to directly improve the long-term viability of the company. I am NOT simply an investor in these names but an acting consultant. This allows me to “overlay my network” and to move the company away from a stressed or defaulting outcome and into an outcome probability that allows the equity price to move substantially higher. Identifying these opportunities has generated shareholders and investors thousands of percentage points in aggregate and is something I’m often recognized by paying subscribers for."
Andy Hecht is a sought-after commodity and futures trader, an options expert and analyst. He spent nearly 35 years on Wall Street, including two decades on the trading desk of Phillip Brothers, which became Salomon Brothers and ultimately part of Citigroup.
Over the past two decades, he has researched, structured and executed some of the largest trades ever made, involving massive quantities of precious metals and bulk commodities.
Andy understands the market in a way many traders can’t imagine. He’s booked vessels, armored cars, and trains to transport and store a broad range of commodities. And he’s worked directly with The United Nations and the legendary trading group Phibro.
Today, Andy remains in close contact with sources around the world and his network of traders.
“I have a vast Rolodex of information in my head… so many bull and bear markets. When something happens, I don’t have to think. I just react. History does tend to repeat itself over and over.”
His friends and mentors include highly regarded energy and precious metals traders, supply line specialists and international shipping companies that give him vast insight into the market.
Andy’s writing and analysis are on many market-based websites including CQG. Andy lectures at colleges and Universities. He also contributes to Traders Magazine. He consults for companies involved in producing and consuming commodities. Andy's biweekly radio show, The Commodities Hour with Andy Hecht, can be heard on Tuesdays and Thursdays from 5-6 PM EST on www.tfnn.com. Andy’s first book How to Make Money with Commodities, published by McGraw-Hill was released in 2013 and has received excellent reviews. Andy held a Series 3 and Series 30 license from the National Futures Association and a collaborator and strategist with hedge funds. Andy is the commodity expert for the website about.com and blogs on his own site technomentals.com.
I have been occasionally investing, as my personal time and money permit, via long positions over the course of 10 years. I don't work for a brokerage firm, and I'm not a professional trader. My interest has been predominantly within the biotechnology and energy sectors.
I'm a CPA licensed in Maryland. I have Bachelor degrees in both Accounting and Finance.
Stock Twits - http://stocktwits.com/Bio_Bull
Twitter - https://twitter.com/Bio_Bull_SA
Gotham City Capital is a private, biotech research company. Our main objective is to provide investors with low-risk, high reward biotech investments and trades. We place the utmost emphasis on small cap bios that specialize in the most promising therapies out there. In our articles, we will aim to be very specific in our strategy, whether it be a catalyst run-up trade, swing trade or long-term investment. We strive to offer consistent opportunities for investors to create high returns on our biotech picks.
With approximately six year of studies, we feel that we have an excellent balance of expertise between trading, company financing, company management and most specifically, trial data. A solid track record of successfully finding the best trades and companies has driven us to start this company. We believe in making decent size bets on the best companies.
For real time market commentary, make sure to follow Gotham City Capital on Twitter.
I'm 32, invest in the light of the Austrian economic tradition, which in today's environment means mostly precious metals and mining stocks using cycles and sentiment as timing mechanisms. ETF's, options, I also own some physical. I've been doing this independently for 3 years. I reserve a small chunk of my portfolio for speculating in biotech and technology where I believe appropriate.
John Eastman is a writer, mixed media artist, and founder of several businesses (www.redfishcreative.com) (www.eastmantribe.com)with over 25 years of hands-on business and entrepreneurial experience. He currently works and resides in a studio loft in Pittsburgh, Pennsylvania and NYC. Mr. Eastman has exhibited and read in various galleries and exhibits in the region as an artist and writer.
Mr. Eastman is the co-founder of www.smallcapcity.com, an online publication that focuses on small capitalized public firms, founder of www.blackandwhiteprogram.com, an online publication offering interviews, essays, and reports. He also writes for www.thechairmansblog.com, www.smallcapcity.com, Motley Fool, and several other online and print publications.
Mr. Eastman’s business background commenced in 1985 with the launch of a series of high tech, real estate, and design firms. He has extensive experience in banking and loan servicing, real estate property management and asset management, asset appraisal and valuation, Office of Thrift Supervision (OTS) and FDIC bank closure proceedings.
JDT investments is an investment group composed of three brothers named John, Joel, and Jacob Damerow. We look for new information, ask questions, and make informed trades based on our research. We deal primarily with small-cap stocks, and are fascinated with the biotech sector as a whole. We wish to present facts to others, and to inform individuals about new changes in the sector. We believe this area offers the greatest potential, if invested in wisely of course, and we strive to distribute that potential to our family, friends, and all of those who are eager to hear our opinions.Long Athersys.
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage.
The purpose of this profile is to allow us to share with our readers new transcript-related developments.
SA Transcripts Team